Wegovy Approved for Fatty Liver (and it works better than expected)

Did you know that nearly one in three people with obesity may have fatty liver disease without even knowing it? In this episode, I talk about groundbreaking news in obesity and liver health, focusing on the FDA’s recent approval of WeGovy to treat metabolic dysfunction associated steatohepatitis (MASH) with moderate to advanced fibrosis. I share a personal story about a friend who once struggled with fatigue, abnormal liver tests, and fatty liver disease, highlighting how limited treatment options used to be. I explain what MASH is, why it’s so serious, and how common it is, especially among people with obesity and metabolic syndrome. Furthermore, I dive into the ESSENCE trial, which showed that WeGovy not only improved liver inflammation and scarring but in some cases even reversed the disease, all while emphasizing that it works best when combined with lifestyle changes like healthy eating and regular activity. Don’t miss this episode where I break down the latest breakthrough in liver and weight loss care that could change your health journey! ============================ FOLLOW ME 👇 Facebook:   / drshellymd   Instagram:   / drshellymd   Twitter:   / drshellymd   LinkedIn:   / drshellymd   Website: https://drshellymd.com/ Podcast: https://drshellymd.com/podcast/ ============================